VTVX HOLDINGS I LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 22233
 
  
 
C07D HETEROCYCLIC COMPOUNDS 21141
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 396
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
  
 
C07K PEPTIDES 1135
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 1446
 
  
 
G06G ANALOGUE COMPUTERS 152

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0157,093 Substituted Imidazole Derivatives and Methods of Use ThereofFeb 21, 17Jun 08, 17[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9120813 Oxadiazoanthracene compounds for the treatment of diabetesDec 01, 14Sep 01, 15[C07D]
9045461 Phenyl-heteroaryl derivatives and methods of use thereofMar 26, 14Jun 02, 15[A61K, C07D]
9034341 Control of RAGE fusion protein glycosylation and RAGE fusion protein compositionsApr 15, 10May 19, 15[A61K, C12P, C07K]
8987295 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereofDec 06, 12Mar 24, 15[A61K, C07D]
8933222 Oxadiazoanthracene compounds for the treatment of diabetesMar 05, 14Jan 13, 15[C07D]
8877192 Rage fusion proteins and methods of useJan 03, 11Nov 04, 14[A61K, C07K]
8741900 Phenyl-heteroaryl derivatives and methods of use thereofFeb 21, 13Jun 03, 14[A61K]
8718994 Ligands for the GLP-1 receptor and methods for discovery thereofApr 08, 09May 06, 14[G06G]
8703766 Oxadiazoanthracene compounds for the treatment of diabetesAug 01, 13Apr 22, 14[A61K, C07D]
8580833 Substituted imidazole derivatives and methods of use thereofSep 23, 10Nov 12, 13[A61K, A01N, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0002,142 PHENYLGLYOXYLIC ACID DERIVATIVES AND THEIR PREPARATION AND USEAbandonedSep 15, 15Jan 07, 16[C07C]
8563742 Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of useExpiredAug 25, 09Oct 22, 13[A61K, C07D]
2013/0142,792 RAGE Fusion Protein Compositions And Methods Of UseAbandonedOct 19, 10Jun 06, 13[C07K]
8377983 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitorsExpiredFeb 10, 10Feb 19, 13[A61K, A01N, C07D]
8344120 Nucleic acid molecules encoding rage fusion proteinsExpiredJun 13, 11Jan 01, 13[C07H]
8211925 Benzamide glucokinase activatorsExpiredApr 27, 07Jul 03, 12[A61K, C07D]
8138185 Urea glucokinase activatorsExpiredJan 08, 08Mar 20, 12[A61K, C07D, A61P]
2011/0039,714 Probes, Systems, and Methods for Drug DiscoveryAbandonedOct 08, 10Feb 17, 11[C40B]
7544699 Aryl and heteroaryl compounds, compositions, and methods of useExpiredAug 06, 04Jun 09, 09[A61K, C07D]
7501538 Aryl and heteroaryl compounds, compositions and methods of useExpiredAug 06, 04Mar 10, 09[C07C]
7459472 Aryl and heteroaryl compounds, compositions, and methods of useExpiredAug 06, 04Dec 02, 08[A61K]
7423177 Carboxamide derivatives as therapeutic agentsExpiredMar 05, 02Sep 09, 08[C07C]
6933303 Heteroaryl-fused nitrogen heterocycles as therapeutic agentsExpiredOct 18, 02Aug 23, 05[A61K, C07D]
6908741 Methods to identify compounds that modulate RAGEExpiredMar 05, 01Jun 21, 05[C12Q, C12N, G01N]
6898549 Automated systems for weighing and/or liquid deliveryExpiredJul 06, 01May 24, 05[G01N, G01G]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.